With the increased understanding of drug mechanisms and disease manifestations, escalated headway in clinical research, and breakthrough pharmaceutical technologies, an unparallel interest has been witnessed towards the realm of novel drug delivery systems. These drug delivery systems have been instrumental in bringing revolutionary changes in the treatment options and the health scenario across the globe. Likewise, the future is primed to unfold an epoch driven by a fusion of biotechnology and nanotechnology, as many drug products oriented on these cutting-edge technologies are already in the pipeline of approval by various key regulatory agencies. Accordingly, it has almost become mandatory for every health professional, pharmaceutical scientist, biotechnologist and nanotechnologist to have the requisite perception of various newer drug delivery systems. The current volume 8 of 12 volume series is a compilation of diverse novel approaches to strategically deliver the drugs to the desired site at the desired rate and concentration. The volume 8 involves discussion on the following topics: o Recent developments in drug delivery systems o Cycle dextrin nano formulations as drug carriers for treatment of skin pathologies o Challenges and opportunities in pulmonary drug delivery o Targeted drug delivery for treatment of periodontal diseases o So operation as a new approach to gene therapy o Janus particles for biomedical and drug delivery applications o Novel approaches for colon drug delivery o Ionic liquids as promising pharmaceutical carriers in drug delivery o Novel drug delivery vehicles for colloidal drug delivery o Carbon nano tubes and their drug delivery applications o Properties and applications of cell permeable peptides o Formulation, application and scientific validation of her bosoms o Development of implantable drug delivery systems o Micronized ethyl cellulose for oral modified-release drug delivery systems o Chatoyant-based drug delivery systems o Traditional foods as delivery vehicles for proboscis and untraced teals o Role of in vitro/in vivo correlation in product development and biowaivers of drug delivery systems o Recent developments in mouth dissolving tablets formulations and designs The volume 8 contains 18 chapters from 63 researchers and/or academicians representing 6 nations, namely India, Japan, Nigeria, Romania, Taiwan ROC and United States of America giving an overview of the various research activities being carried out in different parts of the world in the area of Novel Drug Delivery.
Autorentext
Dr. Bhupinder Singh, Acclaimed globally for his scientific research work on systematically optimized drug delivery and pharmacokinetic modeling, Dr. Bhupinder Singh (Bhoop) has contributed 3 decades of dedicated service towards scientific research and education. Obtaining his entire pharmaceutical education, i.e., B. Pharm., M. Pharm., Ph.D. and D. St. from Panjab University, Chandigarh, he is currently a Professor of Pharmaceutics & Biopharma-ceutics at the University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh. Besides, he is also Honorary Coordinator for the UGC Centre of Advanced Studies (CAS) in Pharmaceutical Sciences. He has earned to his credit over 180 publications in peer-reviewed journals including 4 books, 1 directory and 23 book chapters. He has handled over a dozen research projects and guided/guiding 25 Ph.D.'s, two post-doctorates and over 50 M. Pharm scholars. A widely travelled scientist, he has shared his experience and expertise at several prestigious professional forums by delivering over 190 keynote, plenary and invited talks in India, USA, Canada, China, and beyond. His work has fetched several awards & accolades like, Leading Educators of World (UK) 2007, Pharma Buzz Pharma Personality Award 2008, Shiksha Rattan Award 2008, Founder Coordinator of Student Research Convention by Association of Indian Universities 2008, India Excellence Inscribed Medal by American Biographic Inst (USA) 2009, DST-PURSE Award for Excellence in University Research 2010, International Peace Prize (USA) 2010, Innovative Scientist Award by CIIPP 2012, Pharma QbD Excellence Award 2012 by CPhI conferences and PuTA Achievement Award 2013. American Association of Pharmaceutical Scientists (AAPS), USA selected one of his drug delivery research for the coveted QbD & Product Performance Award 2012. On industrial fronts, Dr. Singh has 4 patents and key involvement in tech. transfers of two nano-based drug delivery products. Hundreds of industrial scientists have been duly trained under his guidance in India and beyondhd. He is on Editorial Board of over 30 journals and reviewer of over 60 renowned peer-reviewed journals of high impact. Since 2011, he has also been serving as the Founder Coordinator of UGC Centre for Excellence in Biomedical Applications of Nanoparticles. Based on his exemplary accomplishments in Science, Education, Society and Pharma Profession, Mr. Hamid Ansari, Vice President of India has nominated Prof Bhoop to the highest temporal body, Senate of Panjab University, as its Fellow.